CCL2 and COVID-19: found raised blood levels of MCP-1/CCL2 and IP-10/CXCL10 in non-hospitalized COVID-19 patients at 6 months follow-up, which levels did not correlate with fatigue severity (66), similar to our findings in hospitalized patients.